Should I buy ArcBest Corp. (ARCB) stock or is it too late?

ArcBest Corp. · Industrials · price $139

See the full ArcBest Corp. (ARCB) profile

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: UBS — 63% of its targets hit on this sector (83 calls tested). It aims for $154 (+11 %), call made on August 4, 2026, maturing on August 4, 2027 (24 d ago).

The 3 reliable analysts $171+23 %

The 9 other firms $160+15 %

How to read it: the 3 reliable firms are not filtered by optimism — 3 aim above the price, 0 below, hence their $171 median. “The 9 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on ArcBest Corp.

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
Citigroup	100 %	+37.9 %	7	$171 +23%
Stifel	47 %	+30.4 %	17	$176 +27%
Morgan Stanley	67 %	+27.9 %	21	$180 +29%
Truist Securities	60 %	+26.8 %	5	$165 +19%
B of A Securities	61 %	+10.0 %	18	$160 +15%
Credit Suisse	100 %	+40.6 %	6	—
Stephens & Co.	50 %	+12.1 %	6	—

In short — Should you invest in ArcBest Corp.? Is it too late, still worth it? Analysts are fairly positive (58% buy, median target $163, i.e. +17%), and the most reliable on ARCB targets even higher. But it pays virtually no dividend. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

Median price target $163, i.e. +17% from the current price ($139).
The most reliable firm on ARCB, Goldman Sachs (100% hit rate, 2 scored calls), targets $165 (call made on June 23, 2026, maturing on June 23, 2027) (+19%) in its most recent call, and $117 (call made on April 29, 2026, maturing on April 29, 2027) (-16%) in the one coming due soonest.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 12 ratings, 5 are neutral.
A 12-month target is not a guaranteed path: the price can fall in the meantime.
No dividend: your return depends only on price appreciation.

The analyst consensus on ARCB

Median target $163 (+17%) · 12 ratings · Buy consensus

Strong Buy00%

Buy758%

Hold542%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in ArcBest Corp. now?

We won't decide for you. The facts: 58% of analysts rate it a buy, median target $163 (+17%), and Goldman Sachs (most reliable on ARCB, 100%) targets $165. Weigh that against valuation. This is not personalized advice.

Is it too late to invest in ArcBest Corp.?

Not according to analysts: the median target ($163) is still +17% above the current price ($139) (most reliable on ARCB: Goldman Sachs, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is ArcBest Corp. still worth investing in?

It depends on the gap between the price ($139) and its estimated value: analysts target $163 on median (+17%), with 58% buys (most reliable on ARCB: Goldman Sachs, 100%). Cross-check with their real reliability on ARCB and the cautions above. Information, not advice.

What's the main risk in buying ARCB?

The consensus is not unanimous: of 12 ratings, 5 are neutral.

→ Go deeper: the full ArcBest Corp. profile (consensus, analyst reliability, price target, performance).